The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemia

Giovanni Del Poeta, Maria Ilaria Del Principe, Maria Antonietta Irno Consalvo, Luca Maurillo, Francesco Buccisano, Adriano Venditti, Carla Mazzone, Antonio Bruno, Laura Gianni, Giovanni Capelli, Francesco Lo Coco, Maria Cantonetti, Valter Gattei, Sergio Amadori

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences